Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 55, Issue 9, Pages 1198-1204
Publisher
Oxford University Press (OUP)
Online
2012-07-27
DOI
10.1093/cid/cis636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Duration of viral shedding in hospitalized patients infected with pandemic H1N1
- (2011) Silvia Meschi et al. BMC INFECTIOUS DISEASES
- Timing of Oseltamivir Administration and Outcomes in Hospitalized Adults With Pandemic 2009 Influenza A(H1N1) Virus Infection
- (2011) Diego Viasus et al. CHEST
- Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical Trials
- (2011) M. A. Hernan et al. CLINICAL INFECTIOUS DISEASES
- Risk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China
- (2011) Hongjie Yu et al. CLINICAL INFECTIOUS DISEASES
- Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A
- (2011) A. Rodriguez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?
- (2011) N. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico
- (2011) Anjarath Lorena Higuera Iglesias et al. PLoS One
- Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients
- (2010) M. Giannella et al. CLINICAL MICROBIOLOGY AND INFECTION
- Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina
- (2010) Julio A. Farias et al. INTENSIVE CARE MEDICINE
- Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
- (2010) Alicia M. Siston JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry
- (2010) Wiku Adisasmito et al. JOURNAL OF INFECTIOUS DISEASES
- End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening Disease
- (2010) Michael G. Ison et al. JOURNAL OF INFECTIOUS DISEASES
- Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections
- (2010) Lincoln L. H. Lau et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of adults hospitalised with severe influenza
- (2010) N. Lee et al. THORAX
- Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California
- (2009) Janice K. Louie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
- (2009) Seema Jain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome
- (2009) Wanna Hanshaoworakul et al. PLoS One
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
- (2008) Fabrice Carrat et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series
- (2008) I Nyoman Kandun et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started